51. PRKAA1 rs13361707 C/T polymorphism confers decreased susceptibility to esophageal cancer: A case-control study
- Author
-
Jian-Qiang Zhao, Cheng-Lin Li, and Bao Zang
- Subjects
0301 basic medicine ,Microbiology (medical) ,Male ,medicine.medical_specialty ,China ,Esophageal Neoplasms ,Clinical Biochemistry ,AMP-Activated Protein Kinases ,Lower risk ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Immunology and Allergy ,Humans ,Genetic Predisposition to Disease ,esophageal cancer ,Pathological ,Research Articles ,Polymorphism, Genetic ,business.industry ,case‐control study ,Biochemistry (medical) ,Eastern china ,Public Health, Environmental and Occupational Health ,Case-control study ,Distant metastasis ,Histology ,Hematology ,Esophageal cancer ,Middle Aged ,medicine.disease ,PRKAA1 ,Medical Laboratory Technology ,030104 developmental biology ,030220 oncology & carcinogenesis ,Case-Control Studies ,rs13361707 C/T polymorphism ,Female ,business ,Research Article - Abstract
Background Several studies probed into the connection between esophageal cancer (EC) risk and PRKAA1 rs13361707 C/T polymorphism, but obtained insignificant findings. Methods In this study, 814 EC cases and 961 controls from Eastern China were recruited to validate the relationship between this polymorphism and EC susceptibility. Results Data suggested rs13361707 C/T polymorphism in PRKAA1 gene was significantly related with a lower risk for EC. Such significant connection was also uncovered in subgroups of males, smokers, drinkers and individuals with age ≥ 60 years. In addition, this polymorphism was linked with the pathological grading, distant metastasis, and histology of EC. Conclusion In summary, PRKAA1 rs13361707 C/T polymorphism is related to the risk and clinical properties of EC patients in East China.
- Published
- 2020